This polygenic score predicts tamoxifen treatment resistance is better than conventional methods, with potential for personalized medicine application.

One UAB expert says the roles of screenings, warning signs and a healthy lifestyle are all keys to cancer prevention.

Ninety-two percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months. Glioblastoma multiforme is the most aggressive type of cancer originating in the brain.

Shortly before her 34th birthday, King was diagnosed with a grade 2 astrocytoma tumor in her right temporal lobe, and it could not be removed without cutting out part of her brain. Thanks to a clinical trial at UAB, her tumor has stopped growing and has started to shrink.

The award recognizes those in the medical community who have made monumental contributions to cancer prevention, control research and practice.

The ArtBLINK Gala raises funds to help the O’Neal Comprehensive Cancer Center further its mission of advancing the understanding of cancer to improve prevention, detection, treatment and survivorship for all people.

The site-directed addition of a polymer on the antibody trastuzumab helped this cancer-fighting antibody cross the blood-brain barrier.

Ovarian cancer is known as the “silent killer” due to the difficulty in early detection because most women do not have any early symptoms.

IN8bio has opened a new Birmingham facility, a 10,000-square-foot advanced research and development laboratory in the Martin Biscuit Building at Pepper Place.

As one of only five universities selected, UAB joins the NIH’s first major program to address how structural and institutional factors of persistent poverty relate to cancer.

At the O’Neal Comprehensive Cancer Center, a clinical trial and a collaborative care team tackle an aggressive form of T-cell lymphoma in a patient—now a survivor—from Montgomery.

The funding will support 24 research projects at seven institutions in Alabama.

All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.

The list was made by a group that aspires to bolster and increase diversity across all scientific fields, promote retention through the “leaky academic pipeline,” and broaden academic and industrial awareness of diversity and inclusion.

This study was done in mice and with a novel, tissue-engineered, three-dimensional breast cancer mimetic system.

UAB and Proton International open the first proton therapy center for cancer treatment in Alabama.

Fouad’s winning proposal is a comprehensive approach to fixing Alabama’s complex health problems and includes 90 partners on her team from government, business, education and more.

Safe and effective therapeutic agents that can treat these cancer-causing viruses are greatly needed.

Surgeon at UAB believes in making breast cancer awareness an issue year-round to help save lives through early detection.

Blueberries provide nutritious benefits and prevent cell damage that can lead to cancer.